Blue Venture Fund

The Blue Venture Fund is a corporate venture fund established through a collaborative effort among Blue Cross Blue Shield companies. This fund aims to invest in innovative healthcare startups that focus on improving healthcare delivery, enhancing access to services, and promoting health equity. By supporting early-stage companies, the Blue Venture Fund seeks to foster advancements in healthcare technology and solutions that align with the goals of the Blue Cross Blue Shield network, ultimately benefiting the broader healthcare ecosystem.

John Banta

MD

Andrew Boyd

VP

Kelly Carlquist

VP

Tony Chen

Associate

22 past transactions

Upward Health

Venture Round in 2021
Upward Health Inc., a specialty care coordination organization, partners with health plans and providers to help patients with mental illness and substance abuse disorders. The company offers home-based medical and behavioral care for individuals and coordinates with member’s caregivers, their primary care physician, and other medical and behavioral health specialists to ensure the member makes a full recovery and transitions safely back to his/her community. Upward Health Inc. was formerly known as BehaveCare Inc. and changed its name to Upward Health Inc. in July 2019. The company was incorporated in 2017 and is based in Providence, Rhode Island.

Onc.AI

Venture Round in 2020
Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics. The company develops a comprehensive approach to oncology diagnostics and uses deep learning to derive actionable insights into oncology treatment. It was founded in 2020 by Akshay Nanduri and Salmaan Ahmed and is based in San Carlos, California, United States.

Abacus Insights

Series B in 2020
Abacus Insights, Inc. develops a cloud-based data integration and interoperability platform that organizes and exchanges data from various sources and formats for healthcare companies. Its data management platform as a service and analytics application ecosystem that offers healthcare data and provides integrated solutions through the collection of enterprise-wide data, both structured and unstructured. The platform also offers maintenance and support services to the clients. The company was incorporated in 2017 and is based in New York, New York. It has an additional office in Boston, Massachusetts.

Somatus

Series C in 2020
Somatus is a healthcare company that partners with health plans, health systems, and nephrology, and primary care groups. It provides integrated care for patients with or at risk of developing kidney disease. Somatus' is vertically integrated clinical services and technology delay or prevent disease progression, improve quality and care coordination, and increase the use of home dialysis modalities and rates of kidney transplantation. The company is headquartered in McLean, Virginia, and founded by a team of world-class healthcare operators, successful entrepreneurs, and leading clinicians treating kidney disease.

OncoHealth

Series C in 2020
Oncology Analytics, Inc. provides oncology benefits management solutions. Its oncology management services include prior authorization services; clinical decision support, physician education, and expert peer review services; oncology network evaluation and optimization consulting services; and performance reporting and analytics services. The company also provides MATIS, a clinical decision support software used with healthcare plans and providers that enhances oncology analytics evidence-based approach to the evaluation of cancer treatment and benefits management in the United States and Puerto Rico. Oncology Analytics, Inc. was founded in 2009 and is based in Atlanta, Georgia with additional location in Plantation, Florida.

Owl Insights

Venture Round in 2020
Owl Insights, Inc., is the provider of precision-guided behavioral care management technology for behavioral health. Through its advanced platform, affectionately termed “The Owl,” the company offers a scalable strategy to integrate measurement-based care and clinical analytics into existing behavioral health treatment workflows covering all major behavioral health conditions. Owl Insights supports health systems and independent behavioral health organizations nationwide to expand access, improve quality care delivery, better manage costs, and support the preparation for value-based care.

Waltz Health

Series A in 2022
Waltz will work with every partner in the pharmaceutical supply chain, including consumers, payers and pharmacies to create smarter, technology-enabled ways to price, distribute and prescribe medications.

ZeroFox

Post in 2022
ZeroFOX protects organizations from the risks introduced by social networking and digital communication platforms. In an age of constant connectivity and social sharing, users have become the primary target for the adversary. By continuously monitoring social platforms for cyber attacks, information loss, social engineering campaigns, account compromise and fraud, ZeroFOX protects organizations from the next generation of digital threats. Leveraging cutting edge technology and proven security practices, ZeroFOX provides both targeted protection and global insights into the world of social media threats. ZeroFOX, based in Baltimore, MD, has collected a number of industry awards including being recognized as a SINET16 Champion, Security Tech Trailblazer of the Year, one of CRN’s Top 10 Security Companies, 2013 Maryland Cyber Company of the Year, Winner of Chesapeake Regional Technology Council 2014 Rising Star Award, ‘20 Most Promising Security Companies’ by CIO Review, and Daily Record’s ‘Innovator of the Year’. To find out more information about ZeroFOX or to join our team, please visit: https://www.zerofox.com.

Upward Health

Series B in 2022
Upward Health Inc., a specialty care coordination organization, partners with health plans and providers to help patients with mental illness and substance abuse disorders. The company offers home-based medical and behavioral care for individuals and coordinates with member’s caregivers, their primary care physician, and other medical and behavioral health specialists to ensure the member makes a full recovery and transitions safely back to his/her community. Upward Health Inc. was formerly known as BehaveCare Inc. and changed its name to Upward Health Inc. in July 2019. The company was incorporated in 2017 and is based in Providence, Rhode Island.

Octave

Series B in 2020
Octave Bioscience is an early-stage molecular diagnostics company focused on neurodegenerative diseases and conditions. The company was co-founded by Melinda Thomas and William Hagstrom in 2013. Octave Bioscience is headquartered in Menlo Park, California, United States.

Sempre Health

Series B in 2021
Sempre Health, Inc. owns and operates a platform and offers behavior-based healthcare pricing to healthcare industry. The company works with health plans and pharmaceutical manufacturers to dynamically adjust a patient's co-payment based on individual adherence and behavior. It parses prescription records to predict the right price based on the patient's adherence to taking medicines in time. The company provides the patients access to their current discounts, why they got those discounts, and guidance on how to improve their health, via SMS. The company was founded in 2015 and is based in San Francisco, California.

PWNHealth

Private Equity Round in 2020
PWNHealth is a provider of lab connectivity, compliance, and patient outreach solutions. Their platform enables testing solutions for health and wellness, telemedicine, diagnostic labs, and payer markets, who use their services to facilitate quick and seamless consumer access to diagnostic testing and also to maintain compliance with state and federal regulations. Their 50-state physician network and strong technology platform enable them to process over five million diagnostic screens annually.

Capson

Funding Round in 2010
Capson is disrupting the medical malpractice insurance industry. The company's insurances focus not only on the policy but on the experience of physicians and their patients, enabling clients to avail medical insurance at a low premium and resolve claims faster. It was founded in 2010 and headquartered in Austin, Texas.

Contessa

Series C in 2018
Contessa Health, Inc. offers home hospitalization programs to manage episodic risk initiatives. The company provides Home Recovery Care, a risk based model that combines all the elements of inpatient hospital care in the comfort of the patient’s home and an informatics platform to facilitate Home Recovery Care; ContessaCare, a solution that enable providers to deliver hospital-level care to patients in their homes; and ContradoClaim, a claims analytics solution that enable partners to administer prospective payments. Additionally, it offers bundled payment managed services. Contessa Health, Inc. was incorporated in 2014 and is headquartered in Nashville, Tennessee.

Sempre Health

Venture Round in 2023
Sempre Health, Inc. owns and operates a platform and offers behavior-based healthcare pricing to healthcare industry. The company works with health plans and pharmaceutical manufacturers to dynamically adjust a patient's co-payment based on individual adherence and behavior. It parses prescription records to predict the right price based on the patient's adherence to taking medicines in time. The company provides the patients access to their current discounts, why they got those discounts, and guidance on how to improve their health, via SMS. The company was founded in 2015 and is based in San Francisco, California.

Onc.AI

Series A in 2023
Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics. The company develops a comprehensive approach to oncology diagnostics and uses deep learning to derive actionable insights into oncology treatment. It was founded in 2020 by Akshay Nanduri and Salmaan Ahmed and is based in San Carlos, California, United States.

Octave

Series B in 2023
Octave Bioscience is an early-stage molecular diagnostics company focused on neurodegenerative diseases and conditions. The company was co-founded by Melinda Thomas and William Hagstrom in 2013. Octave Bioscience is headquartered in Menlo Park, California, United States.